摘要
目的:观察八正散治疗化学性膀胱炎的临床疗效及安全性。方法:90例化学性膀胱炎患者随机分为治疗组和对照组,每组45例。治疗组给予中药八正散,对照组予西医常规治疗,持续治疗12周。分别于治疗前及治疗后测量O’Leary Saint症状指数、问题指数评分及6个月化疗完成率。结果:两组患者治疗后O’Leary Saint症状指数、问题指数评分比较,差异有统计学意义(P <0. 05)。治疗组6个月化疗完成率91%,对照组为73%,两组比较,差异有统计学意义(P <0. 05)。结论:八正散治疗化学性膀胱炎临床疗效明确,可降低O’Leary Saint症状指数、问题指数评分。
Objective: To observe the clinical efficacy and safety of Bazheng Powder in the treatment of chemical cystitis. Methods:90 patients with chemical cystitis were randomly divided into treatment group and control group,45 cases in each group. The treatment group was treated with Bazheng Powder,while the control group was treated with routine western medicine for 12 weeks. O’Leary Saint symptom index and O’Leary Saint problem index scores and 6-month chemotherapy completion rate were measured before and after treatment. Results: There was significant difference in O’Leary Saint symptom index and O’Leary Saint problem index scores between the two groups after treatment. The difference was statistically significant( P < 0. 05). The 6-month completion rate of chemotherapy in the treatment group was 91% and that in the control group was 73%. There was a significant difference between the two groups( P < 0. 05). Conclusion: Bazheng Powder has a definite clinical effect in the treatment of chemical cystitis,which can reduce O’Leary Saint symptom index and O’Leary Saint problem index scores.
作者
梅雪峰
夏雨果
田英
赵娟
张闯
曾文彤
MEI Xuefeng;XIA Yuguo;TIAN Ying;ZHAO Juan;ZHANG Chuang;ZENG Wentong(Department of Urology,Affiliated Hospital of Chengdu University of Chinese Medicine,Chengdu Sichuan China 610072;Clinical Medical College,Chengdu University of Chinese Medicine,Chengdu Sichuan China 610072)
出处
《中医学报》
CAS
2019年第7期1539-1541,共3页
Acta Chinese Medicine
基金
成都市科技局计划项目(2014-HM01-00252-SF)